Similarly, this pathway was also shown to be involved in the recruitment of type I cytotoxic γδ T cells in melanoma tumors, a hybrid NK/CD8 T lymphocyte able to kill cancer cells, thus conferring an antitumor role of CCL2/CCR2 [95]. This evidence concerns the gene CD8A and cancer.